在人体支气管和肺部中 SARS-CoV-2 Omicron 变异的复制
Kenrie P Y Hui1,2, John C W Ho1, Man-Chun Cheung1
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Nature
|February 1, 2022
概括
与其他变种相比,SARS-CoV-2的Omicron变种在人体支气管中复制得更快,但在肺部效率较低. 这种复制的差异可能会导致Omicron
科学领域:
- 病毒学和分子生物学
- 传染性疾病
- 呼吸系统医学
背景情况:
- 引起关注的SARS-CoV-2变种的出现增加了传染性,构成了全球健康威胁.
- 奥米克朗变种表现出免疫逃避,但其高传染性原因 (免疫逃避与内在性质) 尚不清楚.
- 了解变种特异性病毒学特性对于公共卫生战略至关重要.
研究的目的:
- 为了比较SARS-CoV-2变种 (野生型,D614G,Alpha,Beta,Delta,Omicron) 的复制能力和细胞热带性.
- 调查这些变体对TMPRSS2和细胞进入的甲素的依赖性.
- 将体外发现与观察到的SARS-CoV-2变种的临床严重性模式相关联.
主要方法:
- 用人支气管和肺部的体外培养来评估病毒复制.
- 分析了不同SARS-CoV-2变体的细胞热带性.
- 对每个变体的病毒输入依赖TMPRSS2和cathepsins进行了评估.
主要成果:
- 与其他变异相比,Omicron变异在支气管中复制速度更快,但在肺中复制效率较低.
- 所有令人担忧的变种都表现出与野生型病毒相似的细胞热带性.
- Omicron在细胞进入过程中对甲素的依赖性增加,这表明它有不同的进入途径.
结论:
- 在人类呼吸道中Omicron的独特复制特征可能解释了流行病学研究中观察到的疾病严重程度的降低.
- 不同的复制能力和对甲素的依赖凸显了Omicron变异的独特生物特征.
- 这些发现提供了与SARS-CoV-2变种行为的流行病学观察相关的生物学见解.
更多相关视频
10:12Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids
Published on: March 23, 2022
8.8K
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
1.6K
相关概念视频
Viral Recombination
22.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
22.3K
Viral Mutations
33.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.0K
Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Pneumonia II: Pathophysiology
4.7K
The pathophysiology of pneumonia involves the following steps:
4.7K
